FDA Inspection 967561 — Shandong New Time Pharmaceutical Co. Ltd.
The FDA completed an inspection of Shandong New Time Pharmaceutical Co. Ltd. on Mar 25, 2016 in Linyi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 25, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Linyi (China)